Integrated Care for Irritable Bowel Syndrome: The Future Is Now.

Sameer K Berry, William D Chey

Journal: Gastroenterology clinics of North America 2021;50(3):713-720

PMID: 34304796

Abstract

Irritable bowel syndrome (IBS) is a common symptom-based condition of heterogeneous pathogenesis and clinical phenotype. This heterogeneity and multidimensional nature creates significant diagnostic and treatment challenges. Recent evidence has documented the benefits of diet and behavioral interventions. These nonmedical strategies are causing a shift from the traditional care model to a multidisciplinary care model. Recent evidence suggests that collaborative, team-based integrated care leads to better clinical outcomes and reduced cost per cure compared with traditional care. Although it is growing increasingly clear that integrated care offers significant benefits to IBS patients, widespread dissemination will require solutions to structural, cultural, and financial barriers.

Copyright © 2021 Elsevier Inc. All rights reserved.

Address: Division of Gastroenterology, Michigan Medicine, 1500 East Medical Center Drive, 3910Q Taubman Center, Ann Arbor, MI 48109, USA.; Digestive Health Integrated Care Program, GI Physiology Laboratory, Michigan Food for Life Kitchen, Michigan Bowel Control Program, Division of Gastroenterology, Michigan Medicine, 1500 East Medical Center Drive, 3912 Taubman Center, Ann Arbor, MI 48109-5362, USA. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.